Novel antifungal compounds for pharma and crop protection
This patent covers a set of novel chemical compounds—cyclic peptide-like molecules—isolated from natural sources and shown to have antifungal activity. The compounds can be formulated into pharmaceutical drugs for treating fungal infections in humans or animals, or into agricultural products to protect crops from fungal disease. The patent also covers methods for isolating and purifying these compounds, giving the owner control over both the molecules themselves and the production process.
What you could build
A pharmaceutical antifungal drug candidate or an agricultural fungicide formulation built on these compounds; buyers would be specialty pharma or agrochem companies seeking novel active ingredients to license or develop into products.
Who in Virginia should care
Virginia-based agribusiness operations, tobacco and crop producers, or pharma/biotech companies in the Northern Virginia or Richmond corridors with antifungal pipeline interest.
Readiness: Lab validated
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- Eric W. Schmidt, Joseph O. Falkinham, Peter W. Jeffs
- Granted
- July 22, 2014
- Status
- Granted patent
- Patent number
- 8785376
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.